| Identification | Back Directory | [Name]
5-[[[(3-Chloro-4-fluorophenyl)sulfonyl]amino]methyl]-N-[(2-methyl-5-thiazolyl)methyl]-2-pyrazinecarboxamide | [CAS]
1688684-07-2 | [Synonyms]
5-[[[(3-Chloro-4-fluorophenyl)sulfonyl]amino]methyl]-N-[(2-methyl-5-thiazolyl)methyl]-2-pyrazinecarboxamide | [Molecular Formula]
C17H15ClFN5O3S2 | [MOL File]
1688684-07-2.mol | [Molecular Weight]
455.92 |
| Hazard Information | Back Directory | [Uses]
MPX-004 is a potent GluN2A antagonist. MPX-004 inhibits GluN2A-containing NMDA receptors expressed in HEK cells with an IC50 of 79 nM. MPX-004 has no inhibitory effect on GluN2B or GluN2D receptor-mediated responses. MPX-004 has the potential for neuropsychiatric and developmental disorders research[1]. | [IC 50]
NMDA Receptor | [References]
[1] Robert A Volkmann, et al. MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit. PLoS One. 2016 Feb 1;11(2):e0148129. DOI:10.1371/journal.pone.0148129 |
|
|